Aug 2026· Tremor and Other Hyperkinetic Movements· Vol 16· 0 citations· 45 references
Medicine
TL;DR
It is suggested that sleep-related symptoms may be relevant in ET and support further study with polysomnographic confirmation of RBD and longitudinal follow-up of these symptoms in ET patients.
Abstract
Background: Essential Tremor (ET) has traditionally been regarded as a pure motor disorder. However, emerging evidence suggests associations with non-motor symptoms, including cognitive impairment, psychiatric disturbances, and sleep abnormalities. REM Sleep Behavior Disorder (RBD) is a known prodromal feature of alpha-synucleinopathies such as Parkinson’s disease (PD). The relationship between ET and RBD remains unclear, with previous studies reporting variable prevalence rates. Objective: This study aimed to determine the prevalence of probable RBD (pRBD) among patients with ET using the REM Sleep Behavior Disorder Single-Question Screen (RBD1Q). Methods: In this single-center, cross-sectional study, we identified ET patients from the Parkinson’s Disease Center and Movement Disorders Clinic at Baylor College of Medicine. Eligible patients were contacted and screened for pRBD using the RBD1Q. A small cohort of healthy controls, including spouses, was also screened. Demographic and clinical characteristics were compared between ET patients with and without pRBD. Results: Among 245 ET patients, 21.2% screened positive for pRBD. There were no significant differences in age, age at tremor onset, or tremor duration between patients with and without pRBD. There was a significantly higher percentage of males among ET patients with pRBD (63.5% vs. 48.7%, p = 0.045). Discussion: In this study, pRBD screen positivity was relatively more common in ET patients than historical controls. These findings suggest that sleep-related symptoms may be relevant in ET and support further study with polysomnographic confirmation of RBD and longitudinal follow-up of these symptoms in ET patients.
BACKGROUND
REM sleep behavior disorder (RBD) is now increasingly recognized in progressive supranuclear palsy (PSP), with unclear clinical relevance.
OBJECTIVES
To determine the frequency of pRBD and non-motor symptoms in PSP and association between the two.
METHODS
We enrolled 150 consecutive patients with PSP and...
N. Balaini, Paras Borse, M. S. Girija et al.· Movement Disorders Clinical...· 0 citations
Background Sleep disorders stand as prevalent non-motor symptoms in individuals with amyotrophic lateral sclerosis (ALS) and may be linked to respiratory muscle weakness, neurodegenerative changes, and disruption of sleep architecture. Existing studies have reported considerable variability in the prevalence of sleep d...
Conurrent assessment of olfaction and pRBD may improve clinical phenotyping, but longitudinal validation is required; concurrent assessment of olfaction and pRBD may improve clinical phenotyping, but longitudinal validation is required.
Chia-Yen Lin, Ting-Hsin Chang, Ling-Yu Lin et al.· Frontiers in Aging Neuroscie...· 0 citations
Background: Essential tremor (ET) has been increasingly recognized to involve non-motor symptoms, including sleep disturbances. Essential Tremor Plus (ET-plus), is characterized by additional neurological “soft signs” and may display greater non-motor symptom burden. Despite emerging evidence from polysomnographic stud...
R. Singh, S. Mythirayee, D. Seshagiri et al.· Tremor and Other Hyperkineti...· 0 citations
Background: The relationship between essential tremor (ET) and Parkinson's disease (PD) remains controversial. Beyond viewing ET as a discrete risk factor for PD, recent frameworks propose that an ET phenotype may represent a clinical presentation of prodromal PD (pPD), consistent with the current reconceptualization o...
C. Sorrentino, I. Carotenuto, F. di Biasio et al.· medRxiv· 0 citations
This chapter discusses how RBD provides a window for testing neuroprotective and disease-modifying therapies that may delay or prevent overt synucleinopathy and reviews current symptom management approaches that mix pharmacological treatment with non-pharmacological safety measures for injury prevention and neuromodula...
N. Uzma, Maryam Wajdi, Aasea Alhashmi et al.· Progress in Brain Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.